Literature DB >> 21359530

miR-29b regulates migration of human breast cancer cells.

Chen Wang1, Zhen Bian, Da Wei, Jian-guo Zhang.   

Abstract

microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by targeting mRNAs, inhibiting the expression of the associated proteins. Although a role for aberrant miRNA expression in cancer has been postulated, the pathophysiologic role and relevance of aberrantly expressed miRNAs in tumor biology has not been established. We evaluated the expression pattern of miRNAs in human breast cancer cells by qPCR, finding out an up-regulated miRNA miR-29b and studying its biological effect by migration assay. We defined a target gene PTEN by bioinformatics approach and western blot. In breast cancer cell line MDA-MB-231 cell, which migrate faster than MCF-7, we observed that miR-29b was highly over-expressed. Inhibition of miR-29b in cultured cells increased the expression of the phosphatase and tensin homolog (PTEN) tumor suppressor, promoting apoptosis, decreasing migration, and decreasing invasion. In contrast, enhanced miR-29b expression by transfection with pre-miR-29b decreased the expression of PTEN and impaired apoptosis, increasing tumor cell migration and invasion. Moreover, PTEN was shown to be a direct target of miR-29b and was also shown to contribute to the miR-29b-mediated effects on cell invasion. Modulation of miR-29b altered the role of PTEN involved in cell migration and invasion. Aberrant expression of miR-29b, which modulates PTEN expression, can contribute to migration, invasion, and anti-apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21359530     DOI: 10.1007/s11010-011-0755-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

Review 1.  The regulation of cell migration by PTEN.

Authors:  N R Leslie; X Yang; C P Downes; C J Weijer
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

2.  PTEN and VEGF: possible predictors for sentinel lymph node micro-metastasis in breast cancer.

Authors:  Li Zhu; Wings T Y Loo; W C Chow Louis
Journal:  Biomed Pharmacother       Date:  2007-09-17       Impact factor: 6.529

3.  Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene.

Authors:  Huijuan Wu; Shixuan Wang; Danghui Weng; Hui Xing; Xiaohong Song; Tao Zhu; Xi Xia; Yanjie Weng; Gang Xu; Li Meng; Jianfeng Zhou; Ding Ma
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

Review 4.  The regulation of cell motility and chemotaxis by phospholipid signaling.

Authors:  Verena Kölsch; Pascale G Charest; Richard A Firtel
Journal:  J Cell Sci       Date:  2008-03-01       Impact factor: 5.285

5.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

6.  Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.

Authors:  Alessandra Capodanno; Andrea Camerini; Cinzia Orlandini; Editta Baldini; Maria Letizia Resta; Generoso Bevilacqua; Paola Collecchi
Journal:  Hum Pathol       Date:  2009-05-09       Impact factor: 3.466

Review 7.  MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.

Authors:  Aoife J Lowery; Nicola Miller; Roisin E McNeill; Michael J Kerin
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

8.  Endogenous human microRNAs that suppress breast cancer metastasis.

Authors:  Sohail F Tavazoie; Claudio Alarcón; Thordur Oskarsson; David Padua; Qiongqing Wang; Paula D Bos; William L Gerald; Joan Massagué
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

9.  An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions.

Authors:  S D Selcuklu; M C Yakicier; A E Erson
Journal:  Cancer Genet Cytogenet       Date:  2009-02

10.  MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.

Authors:  Tao Li; Dong Li; Jianjun Sha; Peng Sun; Yiran Huang
Journal:  Biochem Biophys Res Commun       Date:  2009-03-18       Impact factor: 3.575

View more
  54 in total

1.  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).

Authors:  Heng-Jia Liu; Hilaire C Lam; Christian V Baglini; Julie Nijmeh; Alischer A Cottrill; Stephen Y Chan; Elizabeth P Henske
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

2.  Special suppressive role of miR-29b in HER2-positive breast cancer cells by targeting Stat3.

Authors:  Ling Qin; Rong Li; Junyi Zhang; Aimin Li; Rongcheng Luo
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

3.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

4.  A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.

Authors:  Chen Wang; Chao Gao; Jun-Long Zhuang; Chao Ding; Yong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-08-05       Impact factor: 4.553

5.  Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.

Authors:  Penn Muluhngwi; Abirami Krishna; Stephany L Vittitow; Joshua T Napier; Kirsten M Richardson; Mackenzie Ellis; Justin L Mott; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2016-12-13       Impact factor: 8.679

6.  The role of mechanical stretch and TGF-β2 in epithelial-mesenchymal transition of retinal pigment epithelial cells.

Authors:  Qian Cao; Qu-Zhen Deji; Ya-Jun Liu; Wei Ye; Wang-Dui Zhaba; Qin Jiang; Feng Yan
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

7.  Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis.

Authors:  Lei Wang; Jeffrey Ho; Carlotta Glackin; Manuela Martins-Green
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

8.  Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.

Authors:  Roberta Galli; Alessio Paone; Muller Fabbri; Nicola Zanesi; Federica Calore; Luciano Cascione; Mario Acunzo; Antonella Stoppacciaro; Andrea Tubaro; Francesca Lovat; Pierluigi Gasparini; Paolo Fadda; Hansjuerg Alder; Stefano Volinia; Antonio Filippini; Elio Ziparo; Anna Riccioli; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

Review 9.  Small molecules targeting microRNA for cancer therapy: Promises and obstacles.

Authors:  Di Wen; Michael Danquah; Amit Kumar Chaudhary; Ram I Mahato
Journal:  J Control Release       Date:  2015-08-06       Impact factor: 9.776

10.  miR-29b moulds the tumour microenvironment to repress metastasis.

Authors:  Sonia A Melo; Raghu Kalluri
Journal:  Nat Cell Biol       Date:  2013-02       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.